Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-21

Clinical Trial Update: Neuroimaging Predictors of Antidepressant Treatment Outcome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the University of Michigan investigating whether neuroimaging can predict antidepressant treatment outcomes for major depressive d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Depression | Phase 2 | Status: WITHDRAWN